Saliva: A diagnostic biomarker of periodontal diseases

Journal of Indian Society of Periodontology

Volumn 15, Issue 4, 2011, Pages 310-317

  Patil, Priti Basgauda ^a   Patil, Basgauda ^b  

^a Tatyasaheb Kore Dental College and Research Centre   (India)

^b DR D Y PATIL DENTAL COLLEGE AND HOSPITAL   (India)

Author keywords

Biomarker; diagnostic fluid; periodontal diseases; saliva

Indexed keywords

EID: 84861037805     PISSN: 0972124X     EISSN: 09751580     Source Type: Journal    
DOI: 10.4103/0972-124X.92560     Document Type: Review

References (79)

1. Lee Y, Wong DT. Saliva: An emerging biofluid for early detection of disease. Am J Dent 2009;22:241-8.
2. Mandel ID. The diagnostic uses of saliva. J Oral Pathol Med 1990;19:119-25.
3. Giannobile WV, Beikler T, Kinney JS, Ramseier CA, Morelli T, Wong DT. Saliva as a diagnostic tool for periodontal disease: Current state and future directions. Periodontol 2000 2009;50:52-64.
4. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
5. Offenbacher S. Periodontal diseases: Pathogenesis. Ann Periodontol 1996;1:821-78.
6. Sahingur SE, Cohen RE. Analysis of host responses and risk for disease progression. Periodontol 2000 2004;34:57-83.
7. Genco RJ. Current view of risk factors for periodontal diseases. J Periodontol 1996;67(10 Suppl):1041-9.
8. Kaufman I, Lamster IB. Analysis of saliva for periodontal diagnosis: A review. J Clin Periodontol 2000;27:453-65.
9. Marcotte H, Lavoie MC. Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol Molecular Biol Rev 1998;62:71-109.
10. Delacroix DL, Dive C, Rambaud, JC, Vaerman JP. IgA subclasses in various secretions and in serum. Immunology 1982;47:383-5.
11. Guven O, De Visscher JG. Salivary IgA in periodontal disease. J Periodontol 1982;53:334-5.
12. Sandholm L, Gronblad E. Salivary immunoglobulins in patients with juvenile periodontitis and their healthy siblings. J Periodontol 1984;55:9-12.
13. Eggert FM, Maenz L, Tam YC. Measuring the interaction of human secretory glycoproteins to oral bacteria. J Dent Res 1987;66:610-2.
14. Sandholm L, Tolo K, Olsen I. Salivary IgG, a parameter of periodontal disease activity? High responders to actinobacillus actinomycetemcomitans Y4 in juvenile and adult periodontitis. J Clin Periodontol 1987;14:289-94.
15. Jalil RA, Ashley FP, Wilson RF, Wagaiyu EG. Concentrations of thiocyanate, hypothiocyanite, "free" and "total" lysozyme, lactoferrin and secretory IgA in resting and stimulated whole saliva of children aged 12-14 years and the relationship with plaque accumulation and gingivitis. J Periodont Res 1993;28:130-6.
16. Guven Y, Satman I, Dinccag N, Alptekin S. Salivary peroxidase activity in whole saliva of patients with insulin-dependent (type-1) diabetes mellitus. J Clin Periodontol 1996;23:879-81.
17. Sewon L, Karjalainen SM, Sainio M, Seppa O. Calcium and other salivary factors in periodontitis affected subjects prior to treatment. J Clin Periodontol 1995;22:267-70.
18. Groenink J, Walgreen-Weterings E, Nazmi K, Bolscher JG, Veerman EC, van Winkelhoff AJ, et al. Salivary lactoferrin and low-Mr mucin MG2 in Actinobacillus actinomycetemcomitansassociated periodontitis. J Clin Periodontol 1999;26:269-75.
19. Helmerhorst EJ, Oppenheim FG. Saliva: A dynamic proteome. J Dent Res 2007;86:680-93.
20. Henskens YM, van der Velden, U, Veerman ECI, Nieuw Amerongen AV. Cystatins S and C in human whole saliva and in glandular salivas in periodontal health and disease. J Dent Res 1994;73:1606-14.
21. Garito ML, Prihoda TJ, McManus LM. Salivary PAF levels correlate with the severity of periodontal inflammation. J Dental Res 1995;74:1048-56.
22. Syrjanen S, Piironen P, Markkanen H. Free amino-acid composition of wax-stimulated whole saliva in human subjects with healthy periodontium, severe chronic periodontitis and post-juvenile periodontitis. Arch Oral Bio 1984;29:735-8.
23. Syrjanen S, Piironen P, Markkanen H. Free amino-acid content of wax stimulated whole saliva as related to periodontal disease. Arch Oral Biol 1987;32:607-10.
24. Syrjanen S, Alakuijala L, Alakuijala P, Markkanen SO, Markkanen H. Free amino acid levels in oral fluid of normal subjects and patients with periodontal disease. Arch Oral Biol 1990;35:189-93.
25. Wilton JM, Curtis MA, Gillett IR, Griffiths GS, Maiden MF, Sterne JA, et al. Detection of high-risk groups and individuals for periodontal diseases: Laboratory markers from analysis of saliva. J Clin Periodontol 1989;16:475-83.
26. Morgan PR, Shirlaw PJ, Johnson NW, Leigh IM, Lane EB. Potential applications of anti-keratin antibodies in oral diagnosis. J Oral Pathol 1987;16:212-22.
27. Linden GJ, Mullally BH, Freeman R. Stress and the progression of periodontal disease. J Clin Periodontol 1996;23:675-80.
28. Axtelius B, Soderfeldt B, Nilsson A, Edwardsson S, Attstrom R. Therapy-resistant periodontitis. Psychosocial characteristics. J Clin Periodontol 1998;62:482-91.
29. Chrousos GP, Gold PW. The concepts of stress and stress system disorders: Overview of physical and behavioral homeostasis. J Am Med Assoc 1992;267:1244-52.
30. Shannon IL, Prigmore JR, Brooks RA, Feller RP. The 17- hydroxycorticosteroids of parotid fluid, serum and urine following intramuscular administration of repository corticotropin. J Clin Endocrinol 1959;19:1477-80.
31. Genco RJ, Ho AW, Kopman J, Grossi SG, Dunford RG, Tedesco LA. Models to evaluate the role of stress in periodontal disease. Ann Periodontol 1998;3:288-302.
32. Schiott RC, Loe H. The origin and variation in number of leukocytes in the human saliva. J Periodont Res 1970;5:36-41.
33. Klinkhammer J. Quantitative evaluation of gingivitis and periodontal disease (I): The orogranulocyte migratory rate. Periodontics 1968;6:207-11.
34. Raeste AM, Aura A. Rate of migration of oral leukocytes inpatients with periodontitis. Scand J Dent Res 1978;86:43-51.
35. Kopczyk RA, Graham R, Abrams H, Kaplan A, Matheny J, Jasper SJ. The feasibility and reliability of using a home screening test to detect gingival inflammation. J Periodontol 1995;66:52-4.
36. Genco RJ, Zambon JJ, Christersson LA. The role of specific bacteria in periodontal disease: The origin of periodontal infections. Adv Dent Res 1998;2:245-59.
37. Socransky SS. Relationship of bacteria to the etiology of periodontal disease. J Dent Res 1970;49:203-22.
38. Slots J. Bacterial specificity in adult periodontitis: A summary of recent work. J Clin Periodontol 1986;13:912-7.
39. de Jong MH, van der Hoeven JS, van Os JH, Olijve JH. Growth of oral streptococcus species and actinomyces viscosus in human saliva. App Environ Microbiol 1984;47:901-4.
40. de Jong MH, van der Hoeven JS, van Os JH. Growth of microorganisms from supragingival dental plaque on saliva agar. J Dent Res 1986;65:85-8.
41. Asikainen S, Alaluusua S, Saxen L. Recovery of A. actinomycetemcomitans from teeth, tongue and saliva. J Periodontol 1991;62:203-6.
42. Umeda M, Contreras A, Chen C, Bakker I, Slots J. The utility of whole saliva to detect the oral presence of periodontopathic bacteria. J Periodontol 1998;69:828-33.
43. Rosenberg M, Barki M, Portnoy S. A simple method for estimating oral microbial levels. J Microbiol Method 1989;9:253.
44. Tal H, Rosenberg M. Estimation of dental plaque levels and gingival inflammation using a simple oral rinse technique. J Periodontol 1990;61:339-42.
45. Rosenberg M, Kozlovsky A, Gelernter I, Cherniak O, Gabbay J, Baht R, et al. Self-estimation of oral malodor. J Dent Res 1995;74:1577-82.
46. Airila-Mansson S, Soder B, Kari K, Meurman JH. Influence of combinations of bacteria on the levels of prostaglandin E2, interleukin-1beta, and granulocyte elastase in gingival crevicular fluid and on the severity of periodontal disease. J Periodontol 2006;77:1025-31.
47. Kinney JS, Ramseier CA, Giannobile WV. Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann N Y Acad Sci 2007;1098:230-51.
48. Herr AE, Hatch AV, Throckmorton DJ, Tran HM, Brennan JS, Giannobile WV, et al. Microfluidic immunoassays as rapid saliva-based clinical diagnostics. Proc Natl Acad Sci USA 2007;104:5268-73.
49. Teng YT, Sodek J, McCulloch CA. Gingival crevicular fluid gelatinase and its relationship to periodontal disease in human subjects. J Periodontal Res 1992;27:544-52.
50. Hernandez M, Valenzuela MA, Lopez-Otin C, Alvarez J, Lopez JM, Vernal R, et al. Matrix metalloproteinase-13 is highly expressed in destructive periodontal disease activity. J Periodontol 2006;77:863-70.
51. Giannobile WV. C-telopeptide pyridinoline cross-links. Sensitive indicators of periodontal tissue destruction. Ann N Y Acad Sci 1999;878:404-12.
52. Talonpoika JT, Hamalainen MM. Type I collagen carboxyterminal telopeptide in human gingival crevicular fluid in different clinical conditions and after periodontal treatment. J Clin Periodontol 1994;21:320-6.
53. Nakashima K, Giannopoulou C, Andersen E, Roehrich N, Brochut P, Dubrez B, et al. A longitudinal study of various crevicular fluid components as markers of periodontal disease activity. J Clin Periodontol 1996;23:832-8.
54. Sharma CG, Pradeep AR. Gingival crevicular fluid osteopontin levels in periodontal health and disease. J Periodontol 2006;77:1674-80.
55. Sculley DV, Langley-Evans SC. Periodontal disease is associated with lower antioxidant capacity in whole saliva and evidence of increased protein oxidation. Clin Sci (Lond) 2003;105:167-72
56. Mahmood S, Kawanaka M, Kamei A, Izumi A, Nakata K, Niiyama G, et al. Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C. Antioxid Redox Signal 2004;6:19-24.
57. Badea V, Balaban D, Amariei C, Nuca C, Bucur L. Salivary 8-hidroxy-2-deoxy guanosine as oxidative stress biomarker for the diagnosis of periodontal disease. Farmacia 2010;58:5
58. Takane M, Sugano N, Ezawa T, Uchiyama T, Ito K. A marker of oxidative stress in saliva: Association with periodontally-involved teeth of a hopeless prognosis J Oral Sci 2005;47:53-7.
59. Battino M, Ferreiro MS, Gallardo I, Newman HN, Bullon P. The antioxidant capacity of saliva. J Clin Periodontol 2002;29:189-94.
60. Terao J, Nagao A. Antioxidative effect of human saliva on lipid peroxidation. Agr Biol Chem 1991;55:869-72.
61. Moore S, Calder KA, Miller NJ, Rice-Evans CA. Antioxidant activity of saliva and periodontal disease. Free Radical Res 1994;21:417-25.
62. Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 2008;14:6246-52.
63. Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 2004;10:8442-50.
64. Hu S, Wang J, Meijer J, Ieong S, Xie Y, Yu T, et al. Salivary proteomic and genomic biomarkers for primary Sjogren's syndrome. Arthritis Rheum 2007;56:3588-600.
65. Hu S, Xie Y, Ramachandran P, Ogorzalek Loo RR, Li Y, Loo JA, et al. Large-scale identification of proteins in human salivary proteome by liquid chromatographymass spectrometry and twodimensional gel electrophoresis-mass spectrometry. Proteomics 2005;5:1714-28.
66. Denny P, Hagen FK, Hardt M, Liao L, Yan W, Arellanno M, et al. The proteomes of human parotid and submandibular sublingual gland salivas collected as the ductal secretions. J Proteome Res 2008;7:1994-2006.
67. Li Y, Zhou X, St John MA, Wong DT. RNA profiling of cell free saliva using microarray technology. J Dent Res 2004;83:199-203.
68. Ballantyne J. Validity of messenger RNA expression analyses of human saliva. Clin Cancer Res 2007;13:1350;author reply 1351.
69. Nussbaumer C, Gharehbaghi-Schnell E, Korschineck I. Messenger RNA profiling: A novel method for body fluid identification by Real-Time PCR. Forensic Sci Int 2006;157:181-6.
70. Gottfried TD, Mink RW, Phanuphak P. Calypte AWARE HIV-1/2 OMT antibody test using oral fluid: Special challenges of rapid HIV testing in the developing world. Expert Rev Mol Diagn 2006;6: 139-44.
71. Jones JP. In the culture of now: The arrival of the OraQuick rapid HIV test. Posit Aware 2004;15:35-6.
72. Donovan BJ, Rublein JC, Leone PA, Pilcher CD. HIV infection: Point-of-care testing. Ann Pharmacother 2004;38:670-6.
73. Reynolds SJ, Muwonga J. OraQuick ADVANCE Rapid HIV-1/2 antibody test. Expert Rev Mol Diagn 2004;4:587-91.
74. Schipper R, Loof A, de Groot J, Harthoorn L, Dransfield E, van Heerde W. SELDI-TOF-MS of saliva: Methodology and pretreatment effects. J Chromatogr B Analyt Technol Biomed Life Sci 2007;847:45-53.
75. Major CV, Read SE, Coates RA, Francis A, McLaughlin BJ, Millson M, et al. Comparison of saliva and blood for human immunodeficiency virus prevalence testing. J Infect Dis 1991;163:699-702.
76. Griffiths GS. Formation, collection and significance of gingival crevice fluid. Periodontol 2000 2003;31:32-42.
77. Miller CS, Foley JD, Bailey AL, Campell CL, Humphries RL, Christodoulides N, et al. Current developments in salivary diagnostics. Biomark Med 2010;4:171-89.
78. D'Aiuto F, Ready D, Tonetti MS. Periodontal disease and C reactive protein-associated cardiovascular risk. J Periodontal Res 2004;39:236-41.
79. Teng YT, Sodek J, McCulloch CA. Gingival crevicular fluid gelatinase and its relationship to periodontal disease in human subjects. J Periodontal Res 1992;27:544-52.